ID

24515

Descrizione

Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL); ODM derived from: https://clinicaltrials.gov/show/NCT00464633

collegamento

https://clinicaltrials.gov/show/NCT00464633

Keywords

versioni (1)
  1. 04/08/17 04/08/17 -
Caricato su

4 agosto 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Leukemia, Lymphocytic, Chronic NCT00464633

Inglese

Eligibility Leukemia, Lymphocytic, Chronic NCT00464633

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
patient must have documentation of histologically confirmed and measurable chronic lymphocytic leukemia (cll) or prolymphocytic leukemia (pll) arising from cll;
Descrizione

Chronic Lymphocytic Leukemia Measurable | Prolymphocytic Leukemia Due to CLL

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0023434
UMLS CUI [1,2]
C1513040
UMLS CUI [2,1]
C0023486
UMLS CUI [2,2]
C0678226
UMLS CUI [2,3]
C0023434
patient must have symptomatic and progressive disease;
Descrizione

Progressive Disease Symptomatic

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1335499
UMLS CUI [1,2]
C0231220
patient must have received prior alkylating agent(s) and be fludarabine refractory;
Descrizione

Alkylating Agents | Fludarabine refractory

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0002073
UMLS CUI [2,1]
C0059985
UMLS CUI [2,2]
C0205269
patient must have the adequate organ functions;
Descrizione

Organ function

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0678852
patient's eastern cooperative oncology group performance (ecog) status must be 0-2;
Descrizione

ECOG performance status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
patient with de novo pll;
Descrizione

Prolymphocytic Leukemia de novo

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0023486
UMLS CUI [1,2]
C1515568
patient with secondary malignancy that will limit survival ≤5 years;
Descrizione

Secondary Malignant Neoplasm Limiting Continuance of life

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3266877
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0038952
patient with prior allogenic or autologous bone marrow transplant or peripheral blood stem cell transplant ≤12 months;
Descrizione

Allogeneic bone marrow transplantation | Autologous bone marrow transplant | Peripheral Stem Cell Transplantation

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0149615
UMLS CUI [2]
C0194037
UMLS CUI [3]
C0242602
patient receiving an investigational agent or an approved agent for an investigational purpose within last 4 weeks prior to study entry;
Descrizione

Investigational New Drugs | Pharmaceutical Preparations Purpose Investigational

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0013230
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C1285529
UMLS CUI [2,3]
C1517586
patient with known history of glucose-6-phosphate dehydrogenase deficiency;
Descrizione

Deficiency of glucose-6-phosphate dehydrogenase

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2939465
patient with autoimmune hemolytic anemia;
Descrizione

Autoimmune hemolytic anemia

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0002880
patient with known central nervous system involvement;
Descrizione

Central Nervous System Involvement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C4050309
patient with active, uncontrolled serious bacterial, viral or fungal infections
Descrizione

Bacterial Infections Serious Uncontrolled | Virus Diseases Serious Uncontrolled | Mycoses Serious Uncontrolled

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0004623
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C0205318
UMLS CUI [2,1]
C0042769
UMLS CUI [2,2]
C0205404
UMLS CUI [2,3]
C0205318
UMLS CUI [3,1]
C0026946
UMLS CUI [3,2]
C0205404
UMLS CUI [3,3]
C0205318
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Descrizione

Study Subject Participation Status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2348568
Ritorna all'inizio della pagina

Similar models

Eligibility Leukemia, Lymphocytic, Chronic NCT00464633

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Chronic Lymphocytic Leukemia Measurable | Prolymphocytic Leukemia Due to CLL
Item
patient must have documentation of histologically confirmed and measurable chronic lymphocytic leukemia (cll) or prolymphocytic leukemia (pll) arising from cll;
boolean
C0023434 (UMLS CUI [1,1])
C1513040 (UMLS CUI [1,2])
C0023486 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C0023434 (UMLS CUI [2,3])
Progressive Disease Symptomatic
Item
patient must have symptomatic and progressive disease;
boolean
C1335499 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
Alkylating Agents | Fludarabine refractory
Item
patient must have received prior alkylating agent(s) and be fludarabine refractory;
boolean
C0002073 (UMLS CUI [1])
C0059985 (UMLS CUI [2,1])
C0205269 (UMLS CUI [2,2])
Organ function
Item
patient must have the adequate organ functions;
boolean
C0678852 (UMLS CUI [1])
ECOG performance status
Item
patient's eastern cooperative oncology group performance (ecog) status must be 0-2;
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Prolymphocytic Leukemia de novo
Item
patient with de novo pll;
boolean
C0023486 (UMLS CUI [1,1])
C1515568 (UMLS CUI [1,2])
Secondary Malignant Neoplasm Limiting Continuance of life
Item
patient with secondary malignancy that will limit survival ≤5 years;
boolean
C3266877 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0038952 (UMLS CUI [1,3])
Allogeneic bone marrow transplantation | Autologous bone marrow transplant | Peripheral Stem Cell Transplantation
Item
patient with prior allogenic or autologous bone marrow transplant or peripheral blood stem cell transplant ≤12 months;
boolean
C0149615 (UMLS CUI [1])
C0194037 (UMLS CUI [2])
C0242602 (UMLS CUI [3])
Investigational New Drugs | Pharmaceutical Preparations Purpose Investigational
Item
patient receiving an investigational agent or an approved agent for an investigational purpose within last 4 weeks prior to study entry;
boolean
C0013230 (UMLS CUI [1])
C0013227 (UMLS CUI [2,1])
C1285529 (UMLS CUI [2,2])
C1517586 (UMLS CUI [2,3])
Deficiency of glucose-6-phosphate dehydrogenase
Item
patient with known history of glucose-6-phosphate dehydrogenase deficiency;
boolean
C2939465 (UMLS CUI [1])
Autoimmune hemolytic anemia
Item
patient with autoimmune hemolytic anemia;
boolean
C0002880 (UMLS CUI [1])
Central Nervous System Involvement
Item
patient with known central nervous system involvement;
boolean
C4050309 (UMLS CUI [1])
Bacterial Infections Serious Uncontrolled | Virus Diseases Serious Uncontrolled | Mycoses Serious Uncontrolled
Item
patient with active, uncontrolled serious bacterial, viral or fungal infections
boolean
C0004623 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,3])
C0042769 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C0205318 (UMLS CUI [2,3])
C0026946 (UMLS CUI [3,1])
C0205404 (UMLS CUI [3,2])
C0205318 (UMLS CUI [3,3])
Study Subject Participation Status
Item
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
boolean
C2348568 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial